ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

+27.43%
3Y annualised
-0.96% 1D
1M
6M
1Y
3Y
5Y
All
NAV: 27 Mar '26
₹40.32
Min. for SIP
₹100
Fund size (AUM)
₹6,801.16 Cr
Expense ratio
1.05%

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
6 months₹30,000₹27,933
-6.89%
1 year₹60,000₹59,837
-0.27%
3 years₹1,80,000₹2,61,106
+45.06%
5 years₹3,00,000₹5,20,388
+73.46%

Holdings (40)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries Ltd.HealthcareEquity11.21%
Cipla Ltd.HealthcareEquity9.40%
Mankind Pharma Ltd.HealthcareEquity7.64%
Dr. Reddy's Laboratories Ltd.HealthcareEquity6.52%
Biocon Ltd.HealthcareEquity6.20%
Divi's Laboratories Ltd.HealthcareEquity5.95%
Lupin Ltd.HealthcareEquity3.99%
Aurobindo Pharma Ltd.HealthcareEquity3.70%
Alkem Laboratories Ltd.HealthcareEquity3.47%
Syngene International Ltd.HealthcareEquity3.16%
Cohance Lifesciences Ltd.HealthcareEquity2.77%
Medplus Health Services Ltd.HealthcareEquity2.54%
Alivus Life Sciences LtdHealthcareEquity2.11%
Zydus Lifesciences Ltd.HealthcareEquity2.07%
Akums Drugs And Pharmaceuticals Ltd.HealthcareEquity1.77%
JB Chemicals & Pharmaceuticals Ltd.HealthcareEquity1.75%
Thyrocare Technologies Ltd.HealthcareEquity1.75%
Alembic Pharmaceuticals Ltd.HealthcareEquity1.60%
Gland Pharma Ltd.HealthcareEquity1.54%
Entero Healthcare Solutions Ltd.HealthcareEquity1.46%
Pfizer Ltd.HealthcareEquity1.34%
Medi Assist Healthcare Services Ltd.ServicesEquity1.31%
Blue Jet Healthcare Ltd.HealthcareEquity1.22%
Metropolis Healthcare Ltd.HealthcareEquity1.21%
Glenmark Pharmaceuticals Ltd.HealthcareEquity1.19%
Fine Organic Industries Ltd.ChemicalsEquity1.17%
Hikal Ltd.HealthcareEquity1.15%
Anthem Biosciences Ltd.HealthcareEquity1.09%
Aarti Drugs Ltd.HealthcareEquity0.98%
Shilpa Medicare Ltd.HealthcareEquity0.97%
Windlas Biotech Ltd.HealthcareEquity0.95%
Sanofi Consumer Healthcare India Ltd.HealthcareEquity0.88%
Astrazeneca Pharma India Ltd.HealthcareEquity0.76%
Senores Pharmaceuticals Ltd.HealthcareEquity0.71%
FDC Ltd.HealthcareEquity0.63%
Laxmi Dental Ltd.HealthcareEquity0.63%
Nephrocare Health Services Ltd.HealthcareEquity0.48%
Sun Pharma Advanced Research Company Ltd.HealthcareEquity0.45%
Rubicon Research Ltd.HealthcareEquity0.26%
Reserve Bank of IndiaFinancialT-Bills0.03%
See All

Minimum investments

Min. for 1st investment
₹5,000
Min. for 2nd investment
₹1,000
Min. for SIP
₹100

Returns and rankings

Annualised returns
Absolute returns
Name1Y3Y5YAll
Fund returns+3.1%+27.4%+18.1%+19.8%
Category average (Equity Sectoral)-2.1%+22.1%+14.6%--
Rank (Equity Sectoral)1512--

Exit load, stamp duty and tax

Exit load

Exit load of 1% if redeemed within 15 days.

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data

Fund management

SD
Sharmila D'Silva
Jul 2022 - Present
View details

Education
Ms. D'Silva is CA and BAF
Experience
She joined ICICI Prudential AMC Limited in September 2016.
Also manages these schemes

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 12 Oct 1993. Dharmesh Kakkad is the Current Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹11,24,266 Cr and the Latest NAV as of 27 Mar 2026 is ₹40.32. The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹5,000. Exit load of 1% if redeemed within 15 days. ;

Investment Objective

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)#3 in India
Total AUM₹11,24,266.03 Cr
Date of Incorporation12 Oct 1993
Phone--
E-mail--
Launch Date12 Oct 1993
AddressOne BKC , A Wing ,13th Floor, Bandra Kurla Complex, Mumbai 400051
Custodian--
Registrar & Transfer AgentCams
Address7th Floor, Tower II, Rayala Towers, 158, Anna Salai,